Purchase Order 75N95023P00735
- Not listed
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Institute on Drug Abuse to customize software, hardware, and probes for use in implanting devices into rat brains and conducting neural recordings. The contract supports research being conducted by Dr. Schoenbaum at the National Institute on Drug Abuse, part of the Department of Health and Human Services, to advance understanding of...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a firm fixed price purchase order valued at twenty-five thousand dollars by the National Institutes of Health's National Institute on Drug Abuse. Under this contract, Nuvectra will customize software, hardware, and neural probes for implanting into rat brains and conducting neural recordings over a one year period ending in September 2024. The goal of this work supports the National Institute on Drug Abuse's broader...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $75,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Nuvectra to provide an X-DAQ ONE Series electrophysiology recording system, including hardware, software, and silicon recording probes, to support NIDA's biomedical research efforts. Performance...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,978.26 firm fixed price purchase order to Neuronexus Technologies, Inc., doing business as Nuvectra, for data acquisition printed circuit boards to support scientific research. The contract has a period of performance of September 7, 2023 through September 6, 2024. Place of performance will be Nuvectra's facilities in Baltimore, Maryland. No set aside designation or...
- Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $24,232.52 firm fixed-price purchase order by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to deliver X-HEADSTAGE-X6R128-UHDMI-M-ACC neuroscience research equipment. As the prime contractor, Nuvectra will provide the specified headstage products to support the NIH institute's biomedical research efforts. No subcontractors or set-aside designations were...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Neuronexus Technologies, Inc., doing business as Nuvectra. The purpose of this $24,999.00 contract is to procure neural recording probes from Neuronexus that will be used for implanting into rat brains as part of the agency's research efforts. The contract has an ultimate completion date of December 9, 2025. Neuronexus is a...
- This federal contract award from the National Institute of Environmental Health Sciences (NIEHS) is for the procurement of MICROELECTRODE products from Neuronexus Technologies, Inc., doing business as Nuvectra. The $32,685.89 firm fixed-price purchase order contract does not have a set-aside designation. Neuronexus Technologies, a for-profit manufacturer of advanced neuroscience research equipment, has been awarded this contract to provide specialized neural interface products, including...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Plexon, Inc., a for-profit technology company based in Dallas, Texas. The $112,575.00 firm-fixed-price purchase order is for the procurement of specialized research equipment such as neural data acquisition systems, multi-channel electrodes, and other advanced neuroscience instrumentation. This contract supports NIDA's biomedical research...
- This federal contract award, valued at $86,055.00, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Plexon, Inc., a for-profit technology company based in Dallas, Texas. The contract is for the procurement of a Neural Data Acquisition System, which will support advanced biomedical research programs. The contract has a period of performance from August 2, 2019, to August 1, 2020, and was designated as a total small...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $28,080 firm fixed price purchase order to Plexon Inc. to acquire two 32-contact electrodes and two 64-contact electrodes. The purpose of this acquisition is to obtain these electrode products to support the NIH NIDA's biomedical research efforts. Plexon Inc. will serve as the prime contractor to deliver the specified electrodes to the Macaristan place of performance by June 30,...
Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $25,000 firm fixed price purchase order by the National Institute on Drug Abuse, a component of the National Institutes of Health within the Department of Health and Human Services. Under the contract, Nuvectra will provide Microelectrode PCB Adaptors and Passive Commutators to support scientific research. The adaptors and commutators will facilitate HDMI and UHDMI connections for use with X-Series equipment. Performance will occur in Baltimore, Maryland over a one year period from September 2023 through September 2024. No set aside designation or involvement of major subcontractors was indicated. The contract award is consistent with the National Institute on Drug Abuse's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 9/6/23 |